ISMA-RHINA 2024
BackOAS 4 – Rhinosinusitis
Friday 06 Sep, 13:45 PM -
14:45 PM Helsinki, Finland
Fennia I
Oral Abstract Session
13:45
Effects of Dupilumab on Eosinophil Subpopulations and Inflammation in Chronic Rhinosinusitis with Nasal Polyps
13:57
Dupilumab Restores Barrier Function of Nasal Epithelial Cells and Decreases Type-2 Inflammatory Markers in Chronic Rhinosinusitis with Nasal Polyps
14:09
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
14:21
Local nasal inflammation and postoperative wound healing is improved by postoperative doxycycline therapy after FESS in Chronic Rhinosinusitis patients
14:33
Comparison of limited and complete endoscopic sinus surgery in CRSwNP - outcomes of 1-year follow-up
